IGFBP7 and glioblastoma: Similarly, a nanobody directed against insulin-like growth factor-binding protein 7 (IGFBP7; VHH 4.43), was able to selectively detect glioblastoma (GBM) blood vessels after systemic injection in orthotopic GBM mouse models [66].